HomeCompareHOLX vs ORCL

HOLX vs ORCL: Dividend Comparison 2026

HOLX yields 2.65% · ORCL yields 1.44%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ORCL wins by $823.1K in total portfolio value· pulled ahead in Year 2
10 years
HOLX
HOLX
● Live price
2.65%
Share price
$75.55
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$23.6K
Annual income
$314.03
Full HOLX calculator →
ORCL
ORCL
● Live price
1.44%
Share price
$138.78
Annual div
$2.00
5Y div CAGR
77.9%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$846.7K
Annual income
$592,144.13
Full ORCL calculator →

Portfolio growth — HOLX vs ORCL

📍 ORCL pulled ahead of the other in Year 2

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodHOLXORCL
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, HOLX + ORCL cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
HOLX pays
ORCL pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

HOLX
Annual income on $10K today (after 15% tax)
$225.02/yr
After 10yr DRIP, annual income (after tax)
$266.93/yr
ORCL
Annual income on $10K today (after 15% tax)
$122.50/yr
After 10yr DRIP, annual income (after tax)
$503,322.51/yr
At 15% tax rate, ORCL beats the other by $503,055.58/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of HOLX + ORCL for your $10,000?

HOLX: 50%ORCL: 50%
100% ORCL50/50100% HOLX
Portfolio after 10yr
$435.2K
Annual income
$296,229.08/yr
Blended yield
68.07%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ORCL right now

HOLX
Analyst Ratings
18
Buy
23
Hold
1
Sell
Consensus: Hold
Price Target
$77.80
+3.0% upside vs current
Range: $76.00 — $79.00
Altman Z
4.2
Piotroski
7/9
ORCL
Analyst Ratings
55
Buy
27
Hold
4
Sell
Consensus: Buy
Price Target
$285.39
+105.6% upside vs current
Range: $160.00 — $400.00
Altman Z
1.8
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

HOLX buys
0
ORCL buys
0
No recent congressional trades found for HOLX or ORCL in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricHOLXORCL
Forward yield2.65%1.44%
Annual dividend / share$2.00$2.00
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%77.9%
Portfolio after 10y$23.6K$846.7K
Annual income after 10y$314.03$592,144.13
Total dividends collected$2.9K$802.3K
Payment frequencyquarterlyquarterly
SectorHealthcareTechnology
Analyst consensusHoldBuy
Analyst price target$77.80$285.39

Year-by-year: HOLX vs ORCL ($10,000, DRIP)

YearHOLX PortfolioHOLX Income/yrORCL PortfolioORCL Income/yrGap
1$10,965$264.73$10,956$256.38+$9.00HOLX
2← crossover$12,004$271.27$12,190$467.02$186.00ORCL
3$13,121$277.55$13,908$863.93$787.00ORCL
4$14,323$283.54$16,520$1,638.73$2.2KORCL
5$15,615$289.27$20,913$3,236.34$5.3KORCL
6$17,003$294.73$29,188$6,811.58$12.2KORCL
7$18,493$299.93$47,038$15,806.56$28.5KORCL
8$20,093$304.87$92,682$42,351.72$72.6KORCL
9$21,809$309.57$237,913$138,743.46$216.1KORCL
10$23,649$314.03$846,711$592,144.13$823.1KORCL

HOLX vs ORCL: Complete Analysis 2026

HOLXHealthcare

Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The company provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load tests for HIV, Hepatitis C, and Hepatitis B; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays for the detection of SARS-CoV-2; ThinPrep System for use in cytology applications; Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth; and various diagnostic tests for the detection of Group B Streptococcus. It also offers breast imaging and analytics, such as 2D and 3D digital mammography systems and reading workstations, minimally invasive breast biopsy guidance systems and devices, breast biopsy site markers and localization, specimen radiology, and ultrasound and connectivity solutions; and breast conserving surgery products. In addition, the company provides NovaSure Endometrial Ablation System for the treatment of abnormal uterine bleeding; MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids, polyps, and other pathology within the uterus; and Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures. Further, it offers Horizon DXA, a dual energy X-ray system; and the Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. The company sells its products through direct sales and service forces, and independent distributors and sales representatives. Hologic, Inc. was incorporated in 1985 and is headquartered in Marlborough, Massachusetts.

Full HOLX Calculator →

ORCLTechnology

Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing. The company also offers cloud-based industry solutions for various industries; Oracle application licenses; and Oracle license support services. In addition, it provides cloud and license business' infrastructure technologies, such as the Oracle Database, an enterprise database; Java, a software development language; and middleware, including development tools and others. The company's cloud and license business' infrastructure technologies also comprise cloud-based compute, storage, and networking capabilities; and Oracle autonomous database, MySQL HeatWave, Internet-of-Things, digital assistant, and blockchain. Further, it provides hardware products and other hardware-related software offerings, including Oracle engineered systems, enterprise servers, storage solutions, industry-specific hardware, virtualization software, operating systems, management software, and related hardware services; and consulting and customer services. The company markets and sells its cloud, license, hardware, support, and services offerings directly to businesses in various industries, government agencies, and educational institutions, as well as through indirect channels. Oracle Corporation was founded in 1977 and is headquartered in Austin, Texas.

Full ORCL Calculator →
📬

Get this HOLX vs ORCL comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

HOLX vs SCHDHOLX vs JEPIHOLX vs OHOLX vs KOHOLX vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.